• Issue

    European Journal of Haematology: Volume 111, Issue 2

    i, 169-322
    August 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

FEATURED COVER

Free Access

Featured Cover

Irina Amitai,  Kim Roos,  Iran Rashedi,  Yidi Jiang,  Kathryn Mangoff,  Gail Klein,  Nicholas Forward,  Douglas Stewart,  Pierre Laneuville,  Isabelle Bence-Bruckler,  Joy Mangel,  George Tomlinson,  Neil L. Berinstein, 
  • Page: i
  • First Published: 17 July 2023
Featured Cover

The cover image is based on the Original Article PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL by Irina Amitai et al., https://doi.org/10.1111/ejh.13982

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 169-171
  • First Published: 17 July 2023

REVIEW

Open Access

Research progress on the hematopoietic microenvironment in aplastic anemia

Hangchao Li,  Chenjie Zhou,  Yingying Shen,  Min Xu,  Dijiong Wu,  Baodong Ye, 
  • Pages: 172-180
  • First Published: 19 May 2023

ORIGINAL ARTICLES

Open Access

Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP-EBMT study

Nico Gagelmann,  Dirk-Jan Eikema,  Linda Koster,  Tanja Netelenbos,  Andrew McDonald,  Anne-Marie Stoppa,  Roland Fenk,  Achilles Anagnostopoulos,  Gwendolyn van Gorkom,  Eric Deconinck,  Claude-Eric Bulabois,  Michel Delforge,  Donald Bunjes,  William Arcese,  Péter Reményi,  Maija Itälä-Remes,  Lorenz Thurner,  Ali Zahit Bolaman,  Yafour Nabil,  Johan Lund,  Hélène Labussière-Wallet,  Patrick J. Hayden,  Meral Beksac,  Stefan Schönland,  Ibrahim Yakoub-Agha, 
  • Pages: 181-190
  • First Published: 21 April 2023
Open Access

PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL

Irina Amitai,  Kim Roos,  Iran Rashedi,  Yidi Jiang,  Kathryn Mangoff,  Gail Klein,  Nicholas Forward,  Douglas Stewart,  Pierre Laneuville,  Isabelle Bence-Bruckler,  Joy Mangel,  George Tomlinson,  Neil L. Berinstein, 
  • Pages: 191-200
  • First Published: 08 May 2023
PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL

Open Access

Cardiovascular risk in chronic myeloid leukaemia: A multidisciplinary consensus on screening and management

Dragana Milojkovic,  Alexander R. Lyon,  Priyanka Mehta,  Evangelia Dimitriadou,  Satarupa Choudhuri,  Charlotte Manisty,  Nick Cheshire,  Kirsty Crozier,  Nanda Basker,  Karim Amer,  Simon Purcell,  Susan Tan,  Richard E. Clark, 
  • Pages: 201-210
  • First Published: 25 April 2023
Open Access

Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ)

Florence Joly,  Pronabesh DasMahapatra,  Dana B. DiBenedetti,  Katherine Kosa,  Quentin A. Hill, 
  • Pages: 211-219
  • First Published: 02 May 2023

Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation

Bernd Metzner,  Thomas H. Müller,  Jochen Casper,  Christoph Kimmich,  Claus-Henning Köhne,  Eduard Petershofen,  Andrea Renzelmann,  Ruth Thole,  Andreas Voss,  Martin Dreyling,  Eva Hoster,  Wolfram Klapper,  Christiane Pott, 
  • Pages: 220-228
  • First Published: 24 April 2023
Open Access

Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies

Line Dam Heftdal,  Sebastian Rask Hamm,  Laura Pérez-Alós,  Johannes Roth Madsen,  Jose Juan Almagro Armenteros,  Kamille Fogh,  Christoffer Cronwald Kronborg,  Anders Pommer Vallentin,  Rasmus Bo Hasselbalch,  Dina Leth Møller,  Cecilie Bo Hansen,  Mia Pries-Heje,  Anne Ortved Gang,  Sisse Rye Ostrowski,  Ruth Frikke-Schmidt,  Erik Sørensen,  Linda Hilsted,  Henning Bundgaard,  Kasper Iversen,  Peter Garred,  Susanne Dam Nielsen,  Kirsten Grønbæk, 
  • Pages: 229-239
  • First Published: 08 May 2023
Open Access

Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease

Brenda Leeneman,  Hedwig M. Blommestein,  Annemieke van Dongen-Leunis,  Mattia Algeri,  Willem E. Fibbe,  Liesbeth Oosten,  Carin A. Uyl-de Groot,  Frederick W. Thielen, 
  • Pages: 240-246
  • First Published: 03 May 2023

Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone

Emanuele Cencini,  Melania Rocco,  Francesco Ghio,  Federico Simonetti,  Annarosa Cuccaro,  Federica De Marco,  Chiara Consoli,  Monica Bocchia,  Alberto Fabbri, 
  • Pages: 247-253
  • First Published: 10 May 2023
Open Access

Chromosomal breakage tests in the differential diagnosis of Fanconi anemia and aplastic anemia

Gyöngyi Farkas,  Gábor Székely,  Veronika Goda,  Krisztián M. Kállay,  Zsuzsa S. Kocsis,  Katalin Szakszon,  Gábor Benyó,  Dániel Erdélyi,  Zoltán Liptai,  Katalin Csordás,  Gabriella Kertész,  István Szegedi,  Gergely Kriván,  Zoltán Takácsi-Nagy,  Csaba Polgár,  Zsolt Jurányi, 
  • Pages: 254-262
  • First Published: 16 May 2023

A potentially new thromboembolic event scoring system in polycythaemia vera patients: An audit of the Hungarian Philadelphia negative chronic myeloproliferative neoplasia register

Eva Karadi,  Peter Dombi,  Viktoria Gyorine Korom,  Eszter Kovacs,  Jozsef Herczeg,  Hajnalka Andrikovics,  Arpad Illes,  Judit Demeter,  Lajos Homor,  Miklós Udvardy,  Miklós Egyed, 
  • Pages: 263-270
  • First Published: 19 May 2023
Open Access

Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies

Despina Fotiou,  Foteini Theodorakakou,  Maria Gavriatopoulou,  Magdalini Migkou,  Panagiotis Malandrakis,  Ioannis Ntanasis-Stathopoulos,  Nikolaos Kanellias,  Evangelos Eleutherakis Papaiakovou,  Evangelos Terpos,  Asimina Papanikolaou,  Charikleia Gakiopoulou,  Meletios Athanasios Dimopoulos,  Efstathios Kastritis, 
  • Pages: 271-278
  • First Published: 23 May 2023

Augmenter of liver regeneration promotes drug resistance of acute lymphoblastic leukemia through the alteration of mitochondrial functions and the inhibition of the mitochondrial apoptosis pathway

Jingwen Zhou,  Ying Zhou,  Shiyi Yuan,  Yifei Li,  Wenrui Xiao,  Ping Zhang,  Shifeng Lou,  Yan Shen, 
  • Pages: 279-292
  • First Published: 21 June 2023
Open Access

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ≤2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program

Hans-Juergen Laws,  Katsuyuki Fukutake,  Maria Fernanda Lopez-Fernandez,  Yanyan Li,  Wilfried Seifert,  Annarita Tagliaferri, 
  • Pages: 293-299
  • First Published: 26 May 2023
Open Access

Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial

Alexander Röth,  Satoshi Ichikawa,  Yoshikazu Ito,  Jin Seok Kim,  Zsolt Nagy,  Naoshi Obara,  Jens Panse,  Hubert Schrezenmeier,  Simona Sica,  Juliette Soret,  Kensuke Usuki,  Sung-Soo Yoon,  Nadiesh Balachandran,  Muriel Buri,  Pontus Lundberg,  Himika Patel,  Kenji Shinomiya,  Alexandre Sostelly,  Jun-ichi Nishimura, 
  • Pages: 300-310
  • First Published: 15 June 2023

Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting

Giulio Trapè,  Gioia De Angelis,  Marco Morucci,  Michela Tarnani,  Cinzia De Gregoris,  Ambra Di Veroli,  Valentina Panichi,  Giuseppe Topini,  Loredana Bassi,  Raffaella Isidori,  Monica Poscente,  Vincenza Innocenti,  Elisa Emanueli Cippitelli,  Roberta Talucci,  Silvia Bertelli,  Alessandra Crocicchia,  Annalisa Lippi,  Giulia Pezzuti,  Michela Fuschino,  Raffaella Randi,  Cristina Mastini,  Silvia Ciambella,  Gloria Pessina,  Marco Montanaro,  Roberto Latagliata, 
  • Pages: 311-317
  • First Published: 26 May 2023

CASE REPORT

Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody

Abhishek Seth,  David Murray,  Francis K. Buadi,  Morie A. Gertz,  Udit Yadav,  Shaji K. Kumar,  Wilson I. Gonsalves, 
  • Pages: 318-321
  • First Published: 20 May 2023

PLAIN LANGUAGE SUMMARY

Free Access

Assessing the Burden of C5 Inhibitor Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

  • Page: 322
  • First Published: 23 May 2023